<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">38756101</PMID><DateCompleted><Year>2024</Year><Month>08</Month><Day>26</Day></DateCompleted><DateRevised><Year>2024</Year><Month>09</Month><Day>05</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2374-4243</ISSN><JournalIssue CitedMedium="Internet"><Volume>56</Volume><Issue>9</Issue><PubDate><Year>2024</Year><Month>Sep</Month></PubDate></JournalIssue><Title>Infectious diseases (London, England)</Title><ISOAbbreviation>Infect Dis (Lond)</ISOAbbreviation></Journal><ArticleTitle>Biomarkers and genotypes in patients with Central nervous system infection caused by enterovirus.</ArticleTitle><Pagination><StartPage>722</StartPage><EndPage>731</EndPage><MedlinePgn>722-731</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1080/23744235.2024.2345712</ELocationID><Abstract><AbstractText Label="PURPOSE" NlmCategory="UNASSIGNED">Enteroviruses (EV) comprises many different types and are the most common cause of aseptic meningitis. How the virus affects the brain including potential differences between types are largely unknown. Measuring biomarkers in CSF is a tool to estimate brain damage caused by CNS infections.</AbstractText><AbstractText Label="METHODS" NlmCategory="UNASSIGNED">A retrospective study was performed in samples from 38 patients with acute neurological manifestations and positive CSF-EV RNA (<i>n</i> = 37) or serum-IgM (<i>n</i> = 1). The EV in 17 samples were typed by sequencing. The biomarkers neurofilament light (NFL), glial fibrillary acidic protein (GFAP), S-100B protein, amyloid-β (Aβ) 40 and Aβ42, total-tau (T-tau) and phosphorylated tau (P-tau) were measured and compared with data derived from a control group (<i>n</i> = 19).</AbstractText><AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">There were no increased levels of GFAP (<i>p</i> ≤ 0.1) nor NFL (<i>p</i> ≤ 0.1) in the CSF of patients with EV meningitis (<i>n</i> = 38) compared with controls. However, we found decreased levels of Aβ42 (<i>p</i> &lt; 0.001), Aβ40 (<i>p</i> &lt; 0.001), T-tau (<i>p</i> ≥ 0.01), P-tau (<i>p</i> ≤ 0.001) and S-100B (<i>p</i> ≤ 0.001). E30 (<i>n</i> = 9) and CVB5 (<i>n</i> = 6) were the most frequent EV-types identified, but no differences in biomarker levels or other clinical parameters were found between the infecting virus type. Seven patients who were followed for longer than one month reported remaining cognitive impairment, although no correlations with biomarker concentrations were observed.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="UNASSIGNED">There are no indication of neuronal or astrocyte damage in patients with EV meningitis. Yet, decreased concentrations of Aβ40, Aβ42, P-tau and T-tau were shown, a finding of unknown importance. Cognitive impairment after acute disease occurs, but with only a limited number of patients analysed, no conclusion can be drawn concerning any association with biomarker levels or EV types.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Alsén</LastName><ForeName>Karolina</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Institute of Biomedicine, Department of Infectious Diseases, University of Gothenburg, Gothenburg, Sweden.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Infectious diseases, Västra Götaland Region, Sahlgrenska University Hospital, Gothenburg, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Patzi Churqui</LastName><ForeName>Marianela</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Institute of Biomedicine, Department of Infectious Diseases, University of Gothenburg, Gothenburg, Sweden.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Clinical Microbiology, Region Västra Götaland, Sahlgrenska University Hospital, Gothenburg, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Norder</LastName><ForeName>Helene</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Institute of Biomedicine, Department of Infectious Diseases, University of Gothenburg, Gothenburg, Sweden.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Clinical Microbiology, Region Västra Götaland, Sahlgrenska University Hospital, Gothenburg, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rembeck</LastName><ForeName>Karolina</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Institute of Biomedicine, Department of Infectious Diseases, University of Gothenburg, Gothenburg, Sweden.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Infectious diseases, Västra Götaland Region, Sahlgrenska University Hospital, Gothenburg, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zetterberg</LastName><ForeName>Henrik</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Inst. of Neuroscience and Physiology, University of Gothenburg, Mölndal, Sweden.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Clinical Neurochemistry Lab, Sahlgrenska University Hospital, Mölndal, Sweden.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurodegenerative Disease, UCL Institute of Neurology, Queen Square, London, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>UK Dementia Research Institute at UCL, London, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Hong Kong Center for Neurodegenerative Diseases, Hong Kong, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Wisconsin Alzheimer's Disease Research Center, University of Wisconsin School of Medicine and Public Health, University of Wisconsin-Madison, Madison, Wisconsin, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Blennow</LastName><ForeName>Kaj</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Inst. of Neuroscience and Physiology, University of Gothenburg, Mölndal, Sweden.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Clinical Neurochemistry Lab, Sahlgrenska University Hospital, Mölndal, Sweden.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institut du Cerveau et de la Moelle épinière (ICM), Pitié-Salpêtrière Hospital, Sorbonne Université, Paris, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>University of Science and Technology of China, Hefei, P.R. China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sahlgren</LastName><ForeName>Fredrika</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Infectious Diseases, Skövde Hospital, Skövde, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Grahn</LastName><ForeName>Anna</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Institute of Biomedicine, Department of Infectious Diseases, University of Gothenburg, Gothenburg, Sweden.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Infectious diseases, Västra Götaland Region, Sahlgrenska University Hospital, Gothenburg, Sweden.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>05</Month><Day>17</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Infect Dis (Lond)</MedlineTA><NlmUniqueID>101650235</NlmUniqueID><ISSNLinking>2374-4243</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015415">Biomarkers</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016875">tau Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016229">Amyloid beta-Peptides</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D005904">Glial Fibrillary Acidic Protein</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D064568">S100 Calcium Binding Protein beta Subunit</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016900">Neurofilament Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C044882">neurofilament protein L</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C579160">S100B protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C054369">MAPT protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D010446">Peptide Fragments</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015415" MajorTopicYN="Y">Biomarkers</DescriptorName><QualifierName UI="Q000134" MajorTopicYN="N">cerebrospinal fluid</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004770" MajorTopicYN="Y">Enterovirus</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000302" MajorTopicYN="N">isolation &amp; purification</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004769" MajorTopicYN="Y">Enterovirus Infections</DescriptorName><QualifierName UI="Q000134" MajorTopicYN="N">cerebrospinal fluid</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016875" MajorTopicYN="Y">tau Proteins</DescriptorName><QualifierName UI="Q000134" MajorTopicYN="N">cerebrospinal fluid</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016229" MajorTopicYN="Y">Amyloid beta-Peptides</DescriptorName><QualifierName UI="Q000134" MajorTopicYN="N">cerebrospinal fluid</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005904" MajorTopicYN="Y">Glial Fibrillary Acidic Protein</DescriptorName><QualifierName UI="Q000134" MajorTopicYN="N">cerebrospinal fluid</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005838" MajorTopicYN="N">Genotype</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D064568" MajorTopicYN="N">S100 Calcium Binding Protein beta Subunit</DescriptorName><QualifierName UI="Q000134" MajorTopicYN="N">cerebrospinal fluid</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002675" MajorTopicYN="N">Child, Preschool</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016900" MajorTopicYN="N">Neurofilament Proteins</DescriptorName><QualifierName UI="Q000134" MajorTopicYN="N">cerebrospinal fluid</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002494" MajorTopicYN="N">Central Nervous System Infections</DescriptorName><QualifierName UI="Q000134" MajorTopicYN="N">cerebrospinal fluid</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007223" MajorTopicYN="N">Infant</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010446" MajorTopicYN="N">Peptide Fragments</DescriptorName><QualifierName UI="Q000134" MajorTopicYN="N">cerebrospinal fluid</QualifierName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Enterovirus</Keyword><Keyword MajorTopicYN="N">biomarkers</Keyword><Keyword MajorTopicYN="N">central nervous system infection</Keyword><Keyword MajorTopicYN="N">genotypes</Keyword><Keyword MajorTopicYN="N">meningitis</Keyword></KeywordList><CoiStatement>HZ has served at scientific advisory boards and/or as a consultant for Abbvie, Acumen, Alector, Alzinova, ALZPath, Annexon, Apellis, Artery Therapeutics, AZTherapies, Cognito Therapeutics, CogRx, Denali, Eisai, Nervgen, Novo Nordisk, Optoceutics, Passage Bio, Pinteon Therapeutics, Prothena, Red Abbey Labs, reMYND, Roche, Samumed, Siemens Healthineers, Triplet Therapeutics, and Wave, has given lectures in symposia sponsored by Alzecure, Biogen, Cellectricon, Fujirebio, Lilly, and Roche, and is a co-founder of Brain Biomarker Solutions in Gothenburg AB (BBS), which is a part of the GU Ventures Incubator Program (outside submitted work). KB has served as a consultant and at advisory boards for Acumen, ALZPath, BioArctic, Biogen, Eisai, Lilly, Moleac Pte. Ltd, Novartis, Ono Pharma, Prothena, Roche Diagnostics, and Siemens Healthineers; has served at data monitoring committees for Julius Clinical and Novartis; has given lectures, produced educational materials and participated in educational programs for AC Immune, Biogen, Celdara Medical, Eisai and Roche Diagnostics; and is a co-founder of Brain Biomarker Solutions in Gothenburg AB (BBS), which is a part of the GU Ventures Incubator Program, outside the work presented in this paper. The other authors have no relevant financial or non-financial interests to disclose.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>8</Month><Day>26</Day><Hour>13</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>5</Month><Day>17</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>5</Month><Day>17</Day><Hour>3</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>5</Month><Day>17</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38756101</ArticleId><ArticleId IdType="pmc">PMC11371261</ArticleId><ArticleId IdType="doi">10.1080/23744235.2024.2345712</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Omland LH, Holm-Hansen C, Lebech A-M, et al. . Long-term survival, health, social functioning, and education in patients with an enterovirus Central nervous system infection, Denmark, 1997-2016. J Infect Dis. 2020;222(4):619–627. doi: 10.1093/infdis/jiaa151.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jiaa151</ArticleId><ArticleId IdType="pubmed">32236420</ArticleId></ArticleIdList></Reference><Reference><Citation>McGill F, Griffiths MJ, Bonnett LJ, et al. . Incidence, aetiology, and sequelae of viral meningitis in UK adults: a multicentre prospective observational cohort study. Lancet Infect Dis. 2018;18(9):992–1003. doi: 10.1016/S1473-3099(18)30245-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(18)30245-7</ArticleId><ArticleId IdType="pmc">PMC6105576</ArticleId><ArticleId IdType="pubmed">30153934</ArticleId></ArticleIdList></Reference><Reference><Citation>de Crom SC, Rossen JW, van Furth AM, et al. . Enterovirus and parechovirus infection in children: a brief overview. Eur J Pediatr. 2016;175(8):1023–1029. doi: 10.1007/s00431-016-2725-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00431-016-2725-7</ArticleId><ArticleId IdType="pmc">PMC4930465</ArticleId><ArticleId IdType="pubmed">27156106</ArticleId></ArticleIdList></Reference><Reference><Citation>B'Krong NTTC, Minh NNQ, Qui PT, et al. . Enterovirus serotypes in patients with Central nervous system and respiratory infections in Viet Nam 1997-2010. Virol J. 2018;15(1):69. doi: 10.1186/s12985-018-0980-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12985-018-0980-0</ArticleId><ArticleId IdType="pmc">PMC5897964</ArticleId><ArticleId IdType="pubmed">29650033</ArticleId></ArticleIdList></Reference><Reference><Citation>Taravilla CN, Pérez-Sebastián I, Salido AG, et al. . Enterovirus A71 infection and neurologic disease, Madrid, Spain, 2016. Emerg Infect Dis. 2019;25(1):25–32. doi: 10.3201/eid2501.181089.</Citation><ArticleIdList><ArticleId IdType="doi">10.3201/eid2501.181089</ArticleId><ArticleId IdType="pmc">PMC6302576</ArticleId><ArticleId IdType="pubmed">30560775</ArticleId></ArticleIdList></Reference><Reference><Citation>Holm-Hansen CC, Midgley SE, Fischer TK.. Global emergence of enterovirus D68: a systematic review. Lancet Infect Dis. 2016;16(5):e64–e75. doi: 10.1016/S1473-3099(15)00543-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(15)00543-5</ArticleId><ArticleId IdType="pubmed">26929196</ArticleId></ArticleIdList></Reference><Reference><Citation>Messacar K, Abzug MJ, Dominguez SR.. 2014 Outbreak of enterovirus D68 in North america. J Med Virol. 2016;88(5):739–745. doi: 10.1002/jmv.24410.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.24410</ArticleId><ArticleId IdType="pubmed">26489019</ArticleId></ArticleIdList></Reference><Reference><Citation>Petzold A. CSF biomarkers for improved prognostic accuracy in acute CNS disease. Neurol Res. 2007;29(7):691–708. doi: 10.1179/016164107X240080.</Citation><ArticleIdList><ArticleId IdType="doi">10.1179/016164107X240080</ArticleId><ArticleId IdType="pubmed">18173909</ArticleId></ArticleIdList></Reference><Reference><Citation>Chekrouni N, van Soest TM, Brouwer MC, et al. . CSF neurofilament light chain concentrations predict outcome in bacterial meningitis. Neurol Neuroimmunol Neuroinflamm. 2022;9(1):e1123. doi: 10.1212/NXI.0000000000001123.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/NXI.0000000000001123</ArticleId><ArticleId IdType="pmc">PMC8669658</ArticleId><ArticleId IdType="pubmed">34903639</ArticleId></ArticleIdList></Reference><Reference><Citation>Tyrberg T, Nilsson S, Blennow K, et al. . Serum and cerebrospinal fluid neurofilament light chain in patients with Central nervous system infections caused by varicella-zoster virus. J Neurovirol. 2020;26(5):719–726. doi: 10.1007/s13365-020-00889-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13365-020-00889-2</ArticleId><ArticleId IdType="pmc">PMC7532135</ArticleId><ArticleId IdType="pubmed">32816287</ArticleId></ArticleIdList></Reference><Reference><Citation>Gaetani L, Hoglund K, Parnetti L, et al. . A new enzyme-linked immunosorbent assay for neurofilament light in cerebrospinal fluid: analytical validation and clinical evaluation. Alzheimers Res Ther. 2018;10(1):8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6389166</ArticleId><ArticleId IdType="pubmed">29370869</ArticleId></ArticleIdList></Reference><Reference><Citation>Westman G, Aurelius E, Ahlm C, et al. . Cerebrospinal fluid biomarkers of brain injury, inflammation and synaptic autoimmunity predict long-term neurocognitive outcome in herpes simplex encephalitis. Clin Microbiol Infect. 2021;27(8):1131–1136. doi: 10.1016/j.cmi.2020.09.031.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmi.2020.09.031</ArticleId><ArticleId IdType="pubmed">32979577</ArticleId></ArticleIdList></Reference><Reference><Citation>Grahn A, Hagberg L, Nilsson S, et al. . Cerebrospinal fluid biomarkers in patients with varicella-zoster virus CNS infections. J Neurol. 2013;260(7):1813–1821. doi: 10.1007/s00415-013-6883-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-013-6883-5</ArticleId><ArticleId IdType="pubmed">23471614</ArticleId></ArticleIdList></Reference><Reference><Citation>Hampel H, Blennow K, Shaw LM, et al. . Total and phosphorylated tau protein as biological markers of alzheimer’s disease. Exp Gerontol. 2010;45(1):30–40. doi: 10.1016/j.exger.2009.10.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.exger.2009.10.010</ArticleId><ArticleId IdType="pmc">PMC2815003</ArticleId><ArticleId IdType="pubmed">19853650</ArticleId></ArticleIdList></Reference><Reference><Citation>Sulik A, Toczylowski K, Kulczynska-Przybik A, et al. . Amyloid and tau protein concentrations in children with meningitis and encephalitis. Viruses. 2022;14(4):725. doi: 10.3390/v14040725.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v14040725</ArticleId><ArticleId IdType="pmc">PMC9027807</ArticleId><ArticleId IdType="pubmed">35458457</ArticleId></ArticleIdList></Reference><Reference><Citation>Toczylowski K, Wojtkowska M, Sulik A.. Enteroviral meningitis reduces CSF concentration of Aβ42, but does not affect markers of parenchymal damage. Eur J Clin Microbiol Infect Dis. 2019;38(8):1443–1447. doi: 10.1007/s10096-019-03569-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10096-019-03569-0</ArticleId><ArticleId IdType="pmc">PMC6647500</ArticleId><ArticleId IdType="pubmed">31093802</ArticleId></ArticleIdList></Reference><Reference><Citation>Brittain-Long R, Nord S, Olofsson S, et al. . Multiplex real-time PCR for detection of respiratory tract infections. J Clin Virol. 2008;41(1):53–56. doi: 10.1016/j.jcv.2007.10.029.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcv.2007.10.029</ArticleId><ArticleId IdType="pmc">PMC7172039</ArticleId><ArticleId IdType="pubmed">18093871</ArticleId></ArticleIdList></Reference><Reference><Citation>Lindström J, Elfving K, Lindh M, et al. . Assessment of the FilmArray ME panel in 4199 consecutively tested cerebrospinal fluid samples. Clin Microbiol Infect. 2022;28(1):79–84. doi: 10.1016/j.cmi.2021.05.017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmi.2021.05.017</ArticleId><ArticleId IdType="pubmed">34015534</ArticleId></ArticleIdList></Reference><Reference><Citation>Gobom J, Parnetti L, Rosa-Neto P, et al. . Validation of the LUMIPULSE automated immunoassay for the measurement of core AD biomarkers in cerebrospinal fluid. Clin Chem Lab Med. 2022;60(2):207–219. doi: 10.1515/cclm-2021-0651.</Citation><ArticleIdList><ArticleId IdType="doi">10.1515/cclm-2021-0651</ArticleId><ArticleId IdType="pubmed">34773730</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosengren LE, Ahlsén G, Belfrage M, et al. . A sensitive ELISA for glial fibrillary acidic protein: application in CSF of children. J Neurosci Methods. 1992;44(2-3):113–119. doi: 10.1016/0165-0270(92)90004-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0165-0270(92)90004-w</ArticleId><ArticleId IdType="pubmed">1474847</ArticleId></ArticleIdList></Reference><Reference><Citation>Ayukekbong J, Kabayiza J-C, Lindh M, et al. . Shift of enterovirus species among children in Cameroon–identification of a new enterovirus, EV-A119. J Clin Virol. 2013;58(1):227–232. doi: 10.1016/j.jcv.2013.07.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcv.2013.07.005</ArticleId><ArticleId IdType="pubmed">23895932</ArticleId></ArticleIdList></Reference><Reference><Citation>Larsson SB, Vracar D, Karlsson M, et al. . Epidemiology and clinical manifestations of different enterovirus and rhinovirus types show that EV-D68 may still have an impact on severity of respiratory infections. J Med Virol. 2022;94(8):3829–3839. doi: 10.1002/jmv.27767.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.27767</ArticleId><ArticleId IdType="pmc">PMC9321759</ArticleId><ArticleId IdType="pubmed">35403229</ArticleId></ArticleIdList></Reference><Reference><Citation>Kumar S, Stecher G, Li M, et al. . MEGA X: molecular evolutionary genetics analysis across computing platforms. Mol Biol Evol. 2018;35(6):1547–1549. doi: 10.1093/molbev/msy096.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/molbev/msy096</ArticleId><ArticleId IdType="pmc">PMC5967553</ArticleId><ArticleId IdType="pubmed">29722887</ArticleId></ArticleIdList></Reference><Reference><Citation>Krut JJ, Zetterberg H, Blennow K, et al. . Cerebrospinal fluid alzheimer’s biomarker profiles in CNS infections. J Neurol. 2013;260(2):620–626. doi: 10.1007/s00415-012-6688-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-012-6688-y</ArticleId><ArticleId IdType="pubmed">23052602</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamada K, Holth JK, Liao F, et al. . Neuronal activity regulates extracellular tau in vivo. J Exp Med. 2014;211(3):387–393. doi: 10.1084/jem.20131685.</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.20131685</ArticleId><ArticleId IdType="pmc">PMC3949564</ArticleId><ArticleId IdType="pubmed">24534188</ArticleId></ArticleIdList></Reference><Reference><Citation>Ratuszny D, Suhs KW, Novoselova N, et al. . Identification of cerebrospinal fluid metabolites as biomarkers for enterovirus meningitis. Int J Mol Sci. 2019;20(2):337.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6359617</ArticleId><ArticleId IdType="pubmed">30650575</ArticleId></ArticleIdList></Reference><Reference><Citation>Di Stefano A, Alcantarini C, Atzori C, et al. . Cerebrospinal fluid biomarkers in patients with Central nervous system infections: a retrospective study. CNS Spectr. 2020;25(3):402–408. doi: 10.1017/S1092852919000981.</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/S1092852919000981</ArticleId><ArticleId IdType="pubmed">31130152</ArticleId></ArticleIdList></Reference><Reference><Citation>Sjögren M, Gisslén M, Vanmechelen E, et al. . Low cerebrospinal fluid beta-amyloid 42 in patients with acute bacterial meningitis and normalization after treatment. Neurosci Lett. 2001;314(1-2):33–36. doi: 10.1016/s0304-3940(01)02285-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0304-3940(01)02285-6</ArticleId><ArticleId IdType="pubmed">11698140</ArticleId></ArticleIdList></Reference><Reference><Citation>Zetterberg H. Biofluid-based biomarkers for alzheimer’s disease-related pathologies: an update and synthesis of the literature. Alzheimers Dement. 2022;18(9):1687–1693. doi: 10.1002/alz.12618.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/alz.12618</ArticleId><ArticleId IdType="pmc">PMC9514308</ArticleId><ArticleId IdType="pubmed">35213777</ArticleId></ArticleIdList></Reference><Reference><Citation>Gisslén M, Krut J, Andreasson U, et al. . Amyloid and tau cerebrospinal fluid biomarkers in HIV infection. BMC Neurol. 2009;9(1):63. doi: 10.1186/1471-2377-9-63.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2377-9-63</ArticleId><ArticleId IdType="pmc">PMC2807422</ArticleId><ArticleId IdType="pubmed">20028512</ArticleId></ArticleIdList></Reference><Reference><Citation>Dotevall L, Hagberg L, Karlsson JE, et al. . Astroglial and neuronal proteins in cerebrospinal fluid as markers of CNS involvement in lyme neuroborreliosis. Eur J Neurol. 1999;6(2):169–178. doi: 10.1111/j.1468-1331.1999.tb00010.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1468-1331.1999.tb00010.x</ArticleId><ArticleId IdType="pubmed">10053229</ArticleId></ArticleIdList></Reference><Reference><Citation>Studahl M, Rosengren L, Günther G, et al. . Difference in pathogenesis between herpes simplex virus type 1 encephalitis and tick-borne encephalitis demonstrated by means of cerebrospinal fluid markers of glial and neuronal destruction. J Neurol. 2000;247(8):636–642. doi: 10.1007/s004150070134.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s004150070134</ArticleId><ArticleId IdType="pubmed">11041333</ArticleId></ArticleIdList></Reference><Reference><Citation>Posnakoglou L, Tatsi E-B, Chatzichristou P, et al. . Molecular epidemiology of enterovirus in children with Central nervous system infections. Viruses. 2021;13(1):100. doi: 10.3390/v13010100.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v13010100</ArticleId><ArticleId IdType="pmc">PMC7828273</ArticleId><ArticleId IdType="pubmed">33450832</ArticleId></ArticleIdList></Reference><Reference><Citation>Bodilsen J, Mens H, Midgley S, et al. . Enterovirus meningitis in adults: a prospective nationwide Population-Based cohort study. Neurology. 2021;97(5):e454–e63. doi: 10.1212/WNL.0000000000012294.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000012294</ArticleId><ArticleId IdType="pubmed">34088872</ArticleId></ArticleIdList></Reference><Reference><Citation>Verboon-Maciolek MA, Krediet TG, Gerards LJ, et al. . Severe neonatal parechovirus infection and similarity with enterovirus infection. Pediatr Infect Dis J. 2008;27(3):241–245. doi: 10.1097/INF.0b013e31815c1b07.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/INF.0b013e31815c1b07</ArticleId><ArticleId IdType="pubmed">18277927</ArticleId></ArticleIdList></Reference><Reference><Citation>Dunn JJ. Enteroviruses and parechoviruses. Microbiol Spectr. 2016;4(3). doi: 10.1128/microbiolspec.DMIH2-0006-2015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/microbiolspec.DMIH2-0006-2015</ArticleId><ArticleId IdType="pubmed">27337462</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>